Prostate Cancer Treatment and Research
Open access
Peer reviewed
Scollr summary
What this paper is about
No evidence of a clinically relevant tumor sink effect in patients with 2 L) lacks.
Full abstract
Read the full abstract
Abstract Introduction Administration activities of 177 Lu-PSMA were chosen cautiously in the treatment of advanced prostate cancer. The primary aim was to investigate the association between increased injected activities, and the calculated absorbed doses (AD). Methods In this single center, retrospective analysis, patients with PSMA-avid metastatic castration-resistant prostate cancer treated with [ 177 Lu]Lu-PSMA-I&T were included. Patients underwent multiple timepoint SPECT/CT imaging at 24, 48, and 72 h post-injection. Patients included were injected with 7.4, or 9.1 GBq. Segmentations were completed manually for the kidneys (CT-based), while a 3.0 SUV threshold-based approach was used for lesions. Dosimetry calculations were then performed using a multiple-timepoint protocol. Manual verification of the individual segmentations coregistered between timepoints was completed. All time activity data was fit using a mono-exponential function. Time-integrated activity was then convolved with voxel-s-value using a predefined 177 Lu kernel resulting the AD in Gy. No further partial volume corrections were made. Results 76 patients treated were included: 22 and 54 were injected with 9.1 ± 0.3 and 7.4 ± 0.3 GBq respectively. The AD/GBq to the kidney was comparable, 0.29 ± 0.08 vs. 0.33 ± 0.13 Gy/GBq [ p =0.193] (9.1 vs. 7.4 GBq). The tumor AD/GBq was comparable between 9.1 and 7.4 GBq cohorts: total tumor burden (0.95 ± 0.42 vs. 0.92 ± 0.52 Gy/GBq) [ p =0.302]; bone lesions 0.78 ± 0.42 vs. 0.74 ± 0.46 Gy/GBq [ p = 2 L) lacks.
Direct answer
What can I do from this paper page?
Use this page to scan "Influence of increased injected activities up 9.0 GBq [177Lu]Lu-PSMA-I&T on absorbed doses to lesions and kidneys" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Prostate Cancer Treatment and Research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Ells2026Influence,
title = {Influence of increased injected activities up 9.0 GBq [177Lu]Lu-PSMA-I&T on absorbed doses to lesions and kidneys},
author = {Zachary Ells and Linus Hempel and Julia Ells and Muyu Wu and Maximilian Scheifele and Magdalena Schoell and Sophie C. Siegmund and Mathias Zacherl and Rudolf A. Werner and Jeremie Calais and Magnus Dahlbom and Guido Böning and Adrien Holzgreve and Astrid Delker and Lena M. Unterrainer},
journal = {EJNMMI Physics},
year = {2026},
doi = {10.1186/s40658-026-00932-x},
url = {https://doi.org/10.1186/s40658-026-00932-x}
}FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Prostate Cancer Treatment and Research papers?
Follow Prostate Cancer Treatment and Research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Influence of increased injected activities up 9.0 GBq [177Lu]Lu-PSMA-I&T on absorbed doses to lesions and kidneys. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app